Deb Hipp is a freelance health and medical writer and editor who lives in Kansas City, Missouri. She is a former investigative reporter with more than 25 years of experience as a journalist and writer ...

If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to ...

EUCRISA is the first and only 100% steroid-free, topical prescription medication approved for patients as young as 3 months of age in the United States AD is a chronic skin disease characterized by ...

Tapinarof is an investigational, novel, aryl hydrocarbon receptor modulating agent designed as a once-daily, steroid-free topical cream. The Food and Drug Administration (FDA) has accepted for filing ...

Mupirocin is a generic prescription medication. It comes as a topical cream and ointment. The Food and Drug Administration (FDA) has approved these different forms to treat certain bacterial skin ...

Please provide your email address to receive an email when new articles are posted on . Tapinarof cream 1% is already approved for treating adults with plaque psoriasis. Treatment led to improved ...

The global Cream of Tartar Market is estimated to be valued at USD 274.2 million in 2025 and is projected to reach USD 491.0 ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of online ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) ...

LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in ...